Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-03-08
2011-03-08
Wilson, Michael C. (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07902162
ABSTRACT:
The present invention discloses a pharmaceutical composition for treating a subject with immunological recurrent spontaneous abortion which comprises a therapeutically effective amount of a substance capable of lowering the in vivo level of antinuclear antibody. Particularly, the substance is chromosome No. 2 or fragment thereof containing fibronectin encoding gene derived from the spouse of said subject, or a mixture of chromosome No. 2 or fragment thereof containing fibronectin encoding gene derived from a plurality of males. The present invention also discloses a method for treating immunological recurrent spontaneous abortion.
REFERENCES:
patent: 4444879 (1984-04-01), Foster et al.
patent: 5281522 (1994-01-01), Senyei et al.
patent: 5468619 (1995-11-01), Senyei et al.
patent: 2 358 146 (2001-09-01), None
patent: 2 358 146 (2003-03-01), None
patent: 28 36 362 (1980-03-01), None
patent: 9-218202 (1997-08-01), None
patent: 83/00877 (1983-03-01), None
patent: 02/42769 (2002-05-01), None
Gatenby (Am. J. Reprod. Immunol., 1993, vol. 29, No. 2, p. 88-94).
Stricker, R., et al. “Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin.” Fertility and Sterility (2000) vol. 73, No. 3, pp. 536-540.
Pandey, M., et al. “Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion.” Arch Gynecol Obstet (2004) vol. 269, pp. 161-172.
Ramhorst, R., et al. “Intracellular expression of CD69 in endometrial and peripheral T cells . . . leukocyte immunotherapy.” American Journal of Reproductive Immunology (2003) vol. 49, pp. 149-158.
Stricker, R., et al. “Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin.”Fertility and Sterility, vol. 73, No. 3 (Mar. 2000), pp. 536-540.
Ramhorst, R., et al. “Intracellular Expression of CD69 in Endometrial and Peripheral T cells Represents a Useful Marker in Women with Recurrent Miscarriage: Modulation After Allogeneic Leukocyte Immunotherapy.”American Journal of Reproductive Immunology, vol. 49, No. 3 (Mar. 2003), pp. 149-158.
Pandey, M.K., et al. “Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion.”Archives of Gynecology and Obstetrics, vol. 269 No. 3 (Mar. 2004), pp. 161-172.
English Abstract: American Chemical Society. Ogasawara, M. et al. “Clinical Significance of β2 Glycoprotein I Dependent Ancicardiolipin Antibody, Lupus Anticoagulant and Antinuclear Antibodies in Patients with Recurrent Miscarriages”Reproductive Immunology(1998) vol. 10, pp. 272-276.
English Abstract: American Chemical Society. Kano, T. et al. “The Incidence of Endometriosis and Adenomyosis in Patients with Habitual Abortion in Relation to Immunological Abnormalities”Nippon Funin Gakkai Zasshi(1997) vol. 42, No. 2 , pp. 113-118.
Zhang, S. “Methods for Detecting Antinuclear Antibodies and Clinical Significance thereof”Journal of Nephrophathy, Dialysis and Kidney Trnasplantation(1995) vol. 4, Issue 5, pp. 495-497.
U.S. Appl. No. 10/586,285, filed Jul. 2006, Chen.
Ksouri, H, et al. “Recurrent pregnancy loss related to immune disorders.”Ann Med Interne(Paris) (2003) vol. 154, No. 4, pp. 233-247.
Gatenby, P. A., et al. “Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes.”Am. J. Reprod. Immunol. (1993) vol. 29, No. 2, pp. 88-94.
Review Article “Recurrent Pregnancy Losses and the Role of Immunotherapy.”Arch Gynecol Obstet(2000) vol. 264, pp. 3-12.
Feinberg, R. F., et al. “Is Oncofetal Fibronectin a Trophoblast Glue for Human . . . ?”American Journal of Pathology(1991) vol, 138, No. 3.
Chakraborty, C., et al. Reaulation of human trophoblast migration and invasiveness.:Can J Physiol Pharmacol. (2002) vol, 80, No. 2, pp. 116-124.
Koenn, M. E., et al. “Fetal Fibronectin.”Clin Lab Sci(2002) vol. 15, No. 2, pp. 96-98, 115.
Ogasawara, M., et al. “Are antinuclear antibodies predictive of recurrent miscarriage?”Lancet(1996) vol. 347, pp. 1183-1184.
Bernasconi, et al. American Journal of Human Genetics (1996) vol. 59, No. 5 pp. 1114-1118.
Maggio, Immunoenzyme Technique 1 (1980) CRC Press, pp. 186-187.
Aoki, et al. American Journal of Reproductive Immunology (1993) vol. 29, pp. 82-87.
Jones , Acta Endrocrinologica (1975) vol. 78, No. Suppl 94, pp. 376-404 (Abstract Only).
Kwak, et al., Journal of Reproductive Immunology (1995) vol. 28, pp. 175-188.
Gafter, U., et al. “Suppressed cell-mediated immunity and monocyte and natural killer cell activity following allogeneic immunization of women with spontaneous recurrent abortion.”Journal of Clinical Immunology(1997) Plenum Publishing Co., vol. 17, pp. 415-418.
Perdriger, A., et al. “The genetic basis for systemic lupus erythematosus.”Joint Bone Spine(2003) vol. 70, pp. 103-108.
Beijin Xinjing Antai Medical and Technology Service Limited Corp
Ladas & Parry LLP
Wilson Michael C.
LandOfFree
Medicament and method for treating recurrent spontaneous... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicament and method for treating recurrent spontaneous..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament and method for treating recurrent spontaneous... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2718369